Company: Clonmel Healthcare Ltd.
Legal category: Prescription. GMS. Sport permitted.
Active ingredient: Levocetirizine diHCl 5mg.
Description: White, oval, biconvex film-coated tablets marked L9CZ on one side and 5 on reverse.
Presentation: 30, €5.87.
Indication: Treatment of symptoms of chronic idiopathic urticaria.
Pharmacology: Levocetirizine is a potent and selective antagonist of peripheral H1-receptors. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of certain inflammatory cells and the release of certain mediators associated with the late allergic response.
Dosage: Adults and children 12 years and over: 5mg once daily. Renal impairment: See SPC. Elderly: As per adults. Children: 6-12 years, 5mg once daily. Under 6 years, not recommended.
Contraindications: Hypersensitivity to levocetirizine, any of the excipients, hydroxyzine or any piperazine derivatives. Severe renal impairment (<10ml/min cc). Special precautions: Caution: Epilepsy, patients at risk of convulsions. Driving/using machines. Contains lactose. Pregnancy, lactation.
Drug interactions: Caution: Alcohol.
Adverse drug reactions: Rhinitis (children), somnolence, dizziness, headache, pharyngitis, GI disorders, fatigue.
Full prescribing information and references available from Clonmel Healthcare Ltd. Telephone: (052) 6177777. Fax: (052) 6177791. E-mail: email@example.com